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Abstract 
Background 
Tonsillitis is a common condition with an incidence in UK general practice of 37 
per 1000 population a year1.  Recurrent tonsillitis results in significant morbidity 
and impacts on individuals’ quality of life. This study assesses the morbidity and 
quality of life of adults with recurrent tonsillitis, and the impact of surgical 
intervention on their health state.  
Objectives 
1. To describe disease specific and global quality of life for adults with recurrent 
tonsillitis six months after tonsillectomy, using two instruments: the Health 
Impact of Throat Problems (HITP) and EuroQol-visual analogue scale (EQ-
VAS) questionnaire.  
2. To assess the overall health benefit from tonsillectomy as an intervention 
using the Glasgow Benefit Inventory (GBI). 
3. To assess potential predictors of tonsillectomy benefit.  
Design 
A prospective, observational cohort audit of patients who have fulfilled Scottish 
Intercollegiate Guideline Network (SIGN) criteria for tonsillectomy2.   
Setting: Secondary care, teaching hospital 
Participants: Seventy patients (57 female), median age 20 years (range 13-41).  
Results 
Median pre-operative HITP was 47 (range 15-67), compared to 4 (0-72), (p< 
0.001) 6 months following surgery. Median HITP difference was 39.5 (range -20 
to 75). There was no significant change in global Quality of Life. Median overall 6 
months GBI was 39 (-3-100). Patients had an average of 27 episodes of tonsillitis 
over a period of seven years before “achieving” tonsillectomy, significantly 
higher than the SIGN guidelines of three or more episodes over three years.  
Conclusions 
Recurrent tonsillitis causes a poor disease specific quality of life.  Patients 
experienced a median of three episodes per year for seven years before 
tonsillectomy.  Following tonsillectomy, patients had a significant improvement 
in their disease specific quality of life.  Baseline HITP significantly improved after 
tonsillectomy. The results imply patients with recurrent acute tonsillitis may be 
experiencing undue delay 
 
Introduction 
Tonsillectomy is one of the most commonly performed surgical procedures in 
the UK  accounting for 20% of all operations performed by otolaryngologists and 
we have national guidelines in place giving recommendations on when 
tonsillectomy should be performed2. Tonsillitis is a common condition with an 
incidence in general practice of 37 per 1000 population a year, in the UK1 4. 
Recurrent tonsillitis results in significant morbidity, including time off work5. 
The effectiveness of tonsillectomy for recurrent tonsillitis in adults is still 
controversial. Several studies have demonstrated that tonsillectomy is followed 
by clinically important improvements in patient health 6,7.  However, a recent 
large scale prospective study assessing the overall health related quality of life in 
otolaryngology patients found only a small overall benefit from tonsillectomy8. A 
recent Cochrane Review concluded that “Insufficient information is available on 
the effectiveness of adeno-/tonsillectomy versus non-surgical treatment in 
adults to draw a firm conclusion.”9    
Our team is contributing to the UK NAtional Trial of Tonsillectomy IN Adults 
(NATTINA), a nationally funded trial aiming to provide level one evidence for 
tonsillectomy.   The randomised controlled trial in adults examining 
tonsillectomy versus medical treatment is currently recruiting patients in the UK 
but results will not be available for some years10. 
The aims of this prospective audit were to assess 
1. The morbidity of tonsillitis in adults with regards to disease specific and 
global and quality of life, using a both a disease specific and global quality of 
life tool. 
2. The impact of tonsillectomy on these quality of life measures. 
3. The extent of any derived health benefit from tonsillectomy.    
Materials and Methods 
Ethical considerations 
This prospective audit was approved by the hospital clinical effectiveness 
department. The clinical effectiveness department collected all completed 
questionnaires from the ENT clinic, gave each patient a unique study number, 
entered the results into an anonymised database and sent out follow up 
questionnaires.  All follow up questionnaires were returned to the clinical 
effectiveness department and data was entered into an anonymised database.  
The completed anonymised database was transferred to author W.M.W for 
analysis. 
 
Entry and Exclusion Criteria 
Entry criteria for the study were based on the indication for tonsillectomy.  All 
patients that were recruited had been listed electively for tonsillectomy due to 
recurrent tonsillitis, being identified from general ENT clinics.  It was the policy 
of the local health board that patients aged 13 and above were treated in the 
adult hospital, therefore there were a small number of teenagers included in the 
study.  All patients were listed for tonsillectomy.  After being listed, while in the 
clinic, they were invited to participate in the audit.  
Exclusion criteria were as follows: suspected tonsil malignancy11, tonsillectomy 
for sleep disordered breathing12, adenotonsillectomy, revision tonsil surgery, 
patients listed directly from emergency inpatient admission. Patient recruitment 
ran for one year. 
Any method of dissection removal of the palatine tonsils was included in the 
audit (cold steel, bipolar).  
 
Questionnaires 
The Health Impact of Throat problems (HITP) questionnaire was used as the 
disease specific questionnaire.  It is a 16 item questionnaire that is a translation 
of the Tonsillectomy Outcome Inventory 14 questionnaire13 with two additional 
questions (snoring and halitosis).  The two additional questions were originally 
in the first phase of validation for the TOI 14 questionnaire.   The TOI14 is being 
used to assess throat related quality of life in adults in NATTINA10. The 16 items 
offer categorical response options graded 0 to 5 (5 = most severe; 0 = no 
problem), reflecting patients’ experience of symptoms over the previous six 
months.  Total Score thus ranges from 0–80, with a higher score reflecting 
poorer throat related quality of life. 
1) The EuroQol Visual Analogue Scale (EQ-VAS) was used as the global quality 
of life questionnaire.  It is a visual analogue scale that records the 
respondent’s self-rated health on a vertical, visual analogue scale where the 
endpoints are labelled “Best imaginable health state” (100) and “Worst 
imaginable health state” (0).  This information can be used as a quantitative 
measure of health outcome as judged by the individual respondents.   
2) The Glasgow Benefit Inventory (GBI) was chosen as it has been widely used 
in otolaryngology to assess benefit derived following an intervention. The 
GBI poses 18 questions concerning change in health status resulting from the 
intervention/ management.  The response to each question is based on a five-
point Likert-type scale; these are then scaled and averaged to give a final 
score.  The score ranges from -100 to +100, with negative scores meaning a 
worse outcome after intervention, zero meaning no change and a positive 
score representing benefit. The GBI has three domains, general health, social 
support and physical health, with six items per domain, which can be 
examined independently.  
Patients completed the EuroQol-visual analogue scale (EQ-VAS) and health 
impact of throat problems (HITP) at enrolment in the study before tonsillectomy 
was performed.  Patients also provided demographic data (age, sex) indicated 
the number of episodes of sore throat per year, and duration of history in years.   
Six months’ after tonsillectomy, EQ-VAS, HITP and a GBI were sent to each 
patient for completion.  
 
Statistical Analysis 
All analyses were performed using SPSS v. 21 (IBM). Responses on all 
questionnaires were first tested for normality using the one-sample 
Kolmogorov-Smirnov tests. Multiple measures were shown to have a skewed 
distribution, hence non-parametric tests were used to analyse differences 
(related-samples Wilcoxon signed rank test; rank-sum test for gender 
differences) and correlations (Spearman’s rho). Variables correlated were pre 
and post op EQ-VAS, EQ-VAS difference, GBI Total and subscales, pre and post op 
HITP, HITP difference, age, sore throat episodes.  
  
Results 
From 123 patients (Male: Female ratio, 1:2) who were listed for tonsillectomy 
due to recurrent tonsillitis, 105 proceeded to surgery and were eligible for the 
study. 18 patients decided not to proceed to surgery.  Seventy (67%) patients 
fully completed all pre and post op questionnaires. The median age was 20 years 
(range 13-41), with 13 males and 57 females. The mean duration of tonsillitis 
was 7.3 years with the mean number of episodes each year being 3.8 – an 
average of 27 episodes prior to tonsillectomy.  The SIGN compliance rate was 
96%.   
 
EuroQol-Visual Analogue Scale  
The median pre-operative EQ-VAS score was 85 (40-100) increasing to 90 (40-
100) post operatively (z = 1.65; p = 0.10). The median pre-post difference was-3 
(range -60-60). Forty-one (59%) patients had an EQ-VAS improvement, 17 
patients had a lower score and 12 patients had no change.   EQ-VAS scores were 
independent of gender.   
 
Health Impact of Throat Problems 
The median pre-operative score on the HITP was 47 (range 15 to 67).  The 
median postoperative HITP score was 4 (0 to 72), a very substantial decrease 
(p< 0.001). The median pre-post operative difference was 39.5 (-20-75). Sixty-
five patients (93%) had an improvement in their HITP score post tonsillectomy. 
Results were independent of gender.   
 
GBI 
The median overall postoperative benefit as assessed by the GBI was 39 (-3 to 
100, Table 1).  Overall and subscale GBI scores, as well as all three subscales, 
showed a statistically significant benefit (i.e., either the median was significantly 
positive, or in the case of the Social Support subscale, the skew was significantly 
positive). There was a slightly greater median score among female respondents 
(42) in the GBI general subscale than in males (29, z = 2.28; p = 0.02). 
 
Table 1.  Overall GBI and subscales.   
 Overall GBI General 
Social 
Support 
Physical 
Health 
Median 39 42 0 67 
Range -3 to100 4 to 100 -17 to100 -83 to 100 
Z 7.21 7.28 3.99 6.60 
P < 0.001 < 0.001 < 0.001 < 0.001 
 
Correlations 
As age increased, the pre operative EQ-VAS decreased. Significant correlations 
are shown in Table 2. The post operative EQ-VAS correlated with overall, general 
and physical health subscales of the GBI. The post operative HITP correlated 
with the physical health subscale of the GBI and the post operative EQ-VAS.  The 
GBI social support scale was median rank zero and not surprisingly therefore 
failed to show any meaningful correlations.  
Table 2.  Significant Correlations (Spearman’s rho) between GBI/GBI subscales, 
HITP and EQ-VAS  
 
GBI 
Total 
GBI 
General 
GBI 
Physical 
Health 
Postop 
EQ-
VAS 
Preop 
HITP 
Age 
GBI General 0.963*      
GBI Physical Health 0.673* 0.522*     
Preop EQ-VAS      
-
0.379* 
Postop  EQ-VAS 0.368* 0.339* 0.4*    
Postop  HITP   -0.349* 
-
0.367* 
 
 
HITP Difference     0.793*  
*Asterisk indicates statistically significant correlations at α = 0.05 with 
Bonferroni correction for multiple comparisons (i.e. actual α = 0.005). 
 
There was no correlation between HITP and the total number of sore throat 
episodes per person.  The pre-op HITP showed no correlations.   
Discussion 
This study highlights the hidden morbidity that patients with recurrent tonsillitis 
suffer, with patients having an average of 27 episodes of tonsillitis before 
“achieving” tonsillectomy, waiting an average of seven years in the process. The 
intervention of tonsillectomy significantly improved the HITP score (p<0.0001), 
suggesting that tonsillectomy does significantly improve the disease specific 
burden of chronic tonsillitis. 
 
Benefit of Tonsillectomy compared to other ENT procedures.   
The median overall GBI was considerably higher than some retrospective 
reports of tonsillectomy (17 to 35) in the presence of  lower completion rates 
compared to our study (67% vs. 26- 39%6,14,15).  It was also higher than certain 
prospective reports with less stringent entry criteria 7,16. A GBI median score of 
39 is very favourable in comparison to other common ENT procedures including 
septal surgery (5 - 1517,18) or  functional endoscopic sinus surgery, ( 2319), and  
comparable to surgery for hearing impairment (34 -40)5,16.  The very high level 
of physical health benefit has been reported previously  as has the 
nonresponsiveness of GBI social wellbeing to tonsillectomy7.  
 
Benefit of Tonsillectomy compared to other general operations. 
In 2009 McKinsey reported that £700m of NHS funding is unnecessarily spent on 
operations with limited clinical benefit, which include tonsillectomy, varicose 
vein surgery and inguinal hernia surgery20.  This study adds to the body of 
literature already published that shows tonsillectomy is, on the contrary, highly 
effective in treating adults with recurrent tonsillitis6,7. This series of patients is 
the first series to use EQ-VAS pre and post operatively. The median pre operative 
score is high was 85, comparable to the mean score of the UK national 
questionnaire survey on general health status - 82.521.  Forty-one patients (59%) 
reported an increase in general health as measured by the EQ-VAS, which is 
comparable to the most recent Department of Health figures for hip and knee 
replacement surgery (65% increase of health and 55.1% increase respectively).  
Interestingly, only 37% of groin hernia patients report an increase in general 
health after surgery and only 40% of varicose vein patients22. It may be that the 
EQ-VAS alone is not sensitive enough to identify a statistically significant change 
in global quality of life, and was an inappropriate choice of assessment tool for 
this study. It may also be that the high score reflects a ceiling effect and tonsillitis 
does not have a significant impact on the EQ-VAS.  Furthermore, the stringent 
(SIGN) entry criteria may have so tightly grouped patients that the data 
dispersion is too narrow to detect any such variance. 
 
Value of SIGN Guidelines 
This study highlights the consequences of the more or less universal take up  of 
the SIGN guidelines, which to date lack supporting Level 1 evidence in adults2. 
Previous tonsillectomy audits have largely sought to endorse guideline 
compliance, by demonstration that surgery is confined to those with a ‘qualifying 
minimum’ number of episodes to warrant tonsillectomy23,24.  Conversely, 
avoidance of surgery unless SIGN criteria are met, has presumably contributed to 
the significant drop in tonsillectomy numbers over the past decade25. However, 
this study has shown that there is a, hidden morbidity from recurrent tonsillitis 
that is not currently being addressed.   The current patient pathway in Scotland 
has lead patients to experience two to three times more tonsillitis than the 
minimum required by current SIGN guidelines.  However, unfortunately we don’t 
have historical data to demonstrate conclusively if this morbidity has always 
been present, even before SIGN was introduced.  The associated morbidity that 
comes with this is highlighted by the significant change in HITP after 
tonsillectomy.  Recurrent tonsillitis not only causes a disease burden to the 
individual patient but also results in a wider burden to society due to lost work 
days and recurrent health care utilization.  With the lack of evidence for the 
current SIGN guidelines then other tools should be considered to help select 
patients for tonsillectomy and a tool such as HITP may be of more value.    
 
Weakness of Study 
This study had a follow up period of six months.  As patients experienced an 
average of 3.4 sore throats per year, then it may be that longer follow up may not 
have demonstrated as much benefit.  Furthermore, 33% of the participants that 
completed the first set of questionnaires did not complete the second set of 
questionnaires.  Although the demographics of this group were similar to the 
group that completed all questionnaires we were unable to contact those that 
didn’t respond despite multiple attempts.   
 
In summary our audit demonstrates that patients with recurrent tonsillitis 
experience prolonged morbidity (7 years on average), SIGN guidance has 
usefully supported the avoidance of surgery for milder sore throats. Now, 
however, primary and secondary care clinicians, together with purchasers of 
healthcare need to refocus on the prolonged and excessive morbidity experience 
by those with moderate or severe episodes. Until the ongoing NATTINA study 
provides Level I evidence concerning tonsillectomy effectiveness, clinicians 
should review their own patient pathways and facilitate earlier access to surgery 
where excessive delay is demonstrated. 
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